Skip to main content
. 2021 Apr;12(2):751–761. doi: 10.21037/jgo-20-507

Table 4. Pathology findings for 26 patients undergoing hepatic resection after TARE.

Variable N=26
Hepatocellular carcinoma (HCC) 9 (34.6)
Metastatic colorectal adenocarcinoma 6 (23.1)
Intrahepatic cholangiocarcinoma (iCCA) 6 (23.1)
Metastatic carcinoid tumor 2 (7.7)
Metastatic melanoma 1 (3.8)
Mixed iCCA/HCC 1 (3.8)
Gallbladder carcinoma 1 (3.8)
Margins
   R0 25 (96.2)
   R1 1 (3.8)

, values reported as n (%) unless otherwise indicated. TARE, transarterial radioembolization.